CONSORT 2010 Checklist for a Randomized Controlled Study on Nefopam for Cancer Pain

A CONSORT 2010 checklist accompanies a study evaluating the analgesic efficacy of nefopam, a non-opioid drug, for cancer pain. The underlying trial involved 40 patients with moderate to severe cancer pain, randomly assigned to receive either nefopam or a placebo. Koravee Pasutharnchat authored the associated research paper, which is listed as Open Access on the paperswithcode platform.

Use Cases

• Assessing study reporting quality based on the CONSORT checklist items.
• Analyzing trial design and outcomes for non-opioid cancer pain management based on the described primary and secondary endpoints.
• Comparing patient group allocation and intervention protocols based on the described randomization and dosing schedule.

Strengths

• The dataset is linked to a specific, peer-reviewed clinical trial involving 40 patients.
• The study protocol is clearly described, including a defined primary outcome (significant pain reduction) and secondary outcomes (morphine consumption, side effects).

Limitations

• The actual data table (rows, columns, sample data) is unavailable for inspection; only the checklist and study description are provided.
• Row count and column-level documentation are unknown, which limits suitability assessment for direct analysis.
• Last update date is unknown; freshness unverified.

Provenance

Source

paperswithcode

Collection Method

Likely extracted or referenced from the associated academic publication.